MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia R. Pyzer, David Avigan, Dina Stroopinsky et al.|Blood|2017Cited by 193
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host diseaseMyrna Nahas, Jacalyn Rosenblatt, Haesook T. Kim et al.|Blood|2018Cited by 48
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphomaSalvia Jain, David Avigan, Dina Stroopinsky et al.|Blood|2015Cited by 37
Phase I Clinical Trial Evaluating Abatacept in Patient with Steroid-Refractory Chronic Graft Versus Host DiseaseMyrna Nahas, Jacalyn Rosenblatt, Robert J. Soiffer et al.|Blood|2016Cited by 2
MUC1 Inhibition Overcomes Chemotherapy Resistance in Acute Myeloid LeukemiaMyrna Nahas, Jacalyn Rosenblatt, Dina Stroopinsky et al.|Blood|2015Cited by 2